Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,351–4,375 of 7,816 matching trials · page 175 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Dementia Care Challenges Among a Sample of Informal Caregivers in Egypt NCT05572086 |
NA other |
UNKNOWN | 314 | Assiut University OTHER |
2022-10-07 |
|
Eardream Data Collection in Colombia Supported by ADDF NCT05570370 This is an observational study Runs in: Colombia · 1 site |
NA other |
UNKNOWN | 120 | Swiss Federal Institute of Technology OTHER |
2022-10-06 |
|
Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers NCT03538574 CBT-I; MAP-I Runs in: United States · 1 site |
NA other |
COMPLETED | 139 | University of California, Los Angeles OTHER |
2022-10-04 |
|
Dapagliflozin Effect in Cognitive Impairment in Stroke Trial NCT05565976 Dapagliflozin 10mg Tab; Statins (Cardiovascular Agents); Platelet A... Runs in: Mexico · 1 site |
PHASE2|PHASE3 other |
UNKNOWN | 270 | Jaime Daniel Mondragon OTHER |
2022-10-04 |
|
Analysis of De-identified Data From Commercially-available App Lose It! NCT03136692 Lose It! commercial weight loss app |
NA other |
COMPLETED | 7,007 | Johns Hopkins Bloomberg School of Public Health OTHER |
2022-10-03 |
|
Motor Signature, Falls Risk, and Home-Based Interventions in Older Adults With Mild Cognitive Impairment NCT03839576 Exercise; Computerized training Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 252 | Taipei Medical University OTHER |
2022-10-03 |
|
Talking Mats as Decision Aid for Older People Living With Mild to Moderate Dementia NCT05561998 TalkingMats; Usual conversation method Runs in: Sweden · 3 sites |
NA other |
UNKNOWN | 100 | Göteborg University OTHER |
2022-09-30 |
|
Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment NCT01669200 Medium Chain Triglyceride Oil; Placebo Oil Runs in: United States · 1 site |
NA other |
COMPLETED | 4 | Pennington Biomedical Research Center OTHER |
2022-09-29 |
|
Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis NCT03236792 Ixazomib; Cyclophosphamide; Dexamethasone Runs in: United States · 3 sites |
PHASE1|PHASE2 other |
COMPLETED | 28 | Icahn School of Medicine at Mount Sinai OTHER |
2022-09-29 |
|
Temporal Relations and Exercise Interventions of Various Gait and Cognitive Domains in Older Adults NCT03839563 Exercise Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 189 | Taipei Medical University OTHER |
2022-09-29 |
|
Engaging Caregivers in Dementia Care NCT02552563 Dementia Care Management Runs in: United States · 1 site |
NA other |
COMPLETED | 75 | Corporal Michael J. Crescenz VA Medical Center OTHER_GOV |
2022-09-28 |
|
Study for the Use of TKIs for Treatment of Cognitive Decline Due to Degenerative Dementias NCT02921477 bosutinib Runs in: United States · 1 site |
PHASE1 other |
UNKNOWN | 150 | Neurological Associates of West Los Angeles OTHER |
2022-09-28 |
|
Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias NCT04202770 Exosomes Runs in: United States · 1 site |
NA other |
SUSPENDED | 300 | Neurological Associates of West Los Angeles OTHER |
2022-09-28 |
|
Lymphatic System Health in Alzheimer's Disease NCT04205539 Dexmedetomidine Runs in: United States · 2 sites |
PHASE1 other |
WITHDRAWN | 0 | Neurological Associates of West Los Angeles OTHER |
2022-09-28 |
|
Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease NCT04482413 AstroStem; Placebo |
PHASE2 other |
UNKNOWN | 100 | Nature Cell Co. Ltd. INDUSTRY |
2022-09-28 |
|
Effect of the Group-based Paro Intervention on Physiological and Psychological Outcomes NCT05102201 Paro (social robot) intervention Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 118 | National Tainan Junior College of Nursing OTHER |
2022-09-28 |
|
The Efficacy and Safety of tDCS in Patients With Mild Dementia NCT05495113 YMS-201B (Device: Mind STIM); Sham stimulation using YMS-201B Runs in: South Korea · 2 sites |
NA other |
UNKNOWN | 118 | Ybrain Inc. INDUSTRY |
2022-09-28 |
|
The Effect of Exercise and Cognitive Training on Community-dwelling Older Adults With Dementia. NCT05558839 A 12-week weekly sports and cognitive training intervention. Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 41 | Taipei Veterans General Hospital, Taiwan OTHER_GOV |
2022-09-28 |
|
The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women NCT03681691 Estradiol patch Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 12 | Wake Forest University Health Sciences OTHER |
2022-09-27 |
|
Coaching for Cognition in Alzheimer's (COCOA) NCT03424200 Routine care; Coaching plus routine care Runs in: United States · 1 site |
NA other |
COMPLETED | 54 | Hoag Memorial Hospital Presbyterian OTHER |
2022-09-26 |
|
A Study of E2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid Copathology NCT04764669 E2027 Runs in: Canada; United States · 14 sites |
PHASE2 other |
COMPLETED | 34 | Eisai Inc. INDUSTRY |
2022-09-26 |
|
Anxiety, Stress and Sleep Problems in People With Early Onset Dementia NCT05555381 young-D program Runs in: Belgium · 2 sites |
NA other |
UNKNOWN | 60 | KU Leuven OTHER |
2022-09-26 |
|
Walking Interventions, Cognitive Remediation and Mild Cognitive Impairment NCT01801943 Cognitive Remediation Therapy Group; Walking Intervention (WI) Grou... Runs in: United States · 1 site |
NA other |
TERMINATED | — | Pennington Biomedical Research Center OTHER |
2022-09-23 |
|
Natural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD NCT04406636 Runs in: Canada; France; Germany; United Kingdom; United States · 10 sites |
NA other |
UNKNOWN | 70 | CHDI Foundation, Inc. OTHER |
2022-09-23 |
|
An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD) NCT03712787 Tilavonemab Runs in: Australia; Belgium; Canada; Denmark; Finland; Italy; New ... · 57 sites |
PHASE2 anti-tau |
TERMINATED | 364 | AbbVie INDUSTRY |
2022-09-22 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial